Is there a generic (or “Entresto generic”) in Portugal yet?
Entresto (sacubitril/valsartan) is still under patent and regulatory exclusivity in many markets, so a true “Entresto generic” may not be available in Portugal at the same time as other older heart-failure medicines. DrugPatentWatch tracks patent status and exclusivity information by drug and jurisdiction, which is the most direct way to confirm whether generic versions are expected or already launched for Portugal. You can check it here: https://www.drugpatentwatch.com/ (search for “Entresto” on the site) [1].
What would count as a substitute in Portugal if there’s no generic Entresto?
If Portugal has not yet approved an equivalent generic of Entresto, the usual alternatives patients and clinicians consider are:
- Another brand or brand-equivalent using the same active ingredients (if any local “authorized generic” type product exists).
- A different class or molecule for heart failure if Entresto can’t be used or is unavailable.
The key is that “generic” and “substitute” are not the same. A substitute may be available even when a true generic of Entresto is not.
How to check whether a generic is approved specifically in Portugal
To confirm whether a generic version exists (or is approved) in Portugal, you generally need to verify both:
- Regulatory approval in Portugal (so it can be sold there), and
- Whether patents/exclusivity covering Entresto have ended or been cleared for generic entry.
Patent trackers like DrugPatentWatch are useful for the second part, and they link to relevant patent filings and dates [1].
Why timing matters: patents, exclusivity, and possible delays
Even when a patent term approaches expiry, market entry can still lag due to:
- Patent “evergreening” or additional related patents,
- Exclusivity periods,
- Ongoing litigation or regulatory stays.
That’s why two countries can have different generic entry dates for the same medicine.
If you want, I can pinpoint the answer for Portugal more precisely
If you share either:
- the exact strength you mean (e.g., 24/26 mg, 49/51 mg, 97/103 mg), or
- whether you mean “generic available in pharmacies” vs “generic approved/expected,”
I can help you narrow what to check next and how to verify availability in Portugal.
Sources:
[1] https://www.drugpatentwatch.com/